Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

GE17-5438-01

MabSelect SuRe

Cytiva 17-5438-01, pack of 25 mL

Sinonimo/i:

MabSelect Resin

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
41106500
NACRES:
NA.56

ligand

alkali-stabilized protein A-derived (E. coli)

Confezionamento

pack of 25 mL

Produttore/marchio commerciale

Cytiva 17-5438-01

Condizioni di stoccaggio

(20% Ehtanol)

Matrice

highly cross-linked agarose

Dimens. media delle particelle

85 μm (d₅₀v is the median particle size of the cumulative volume distribution)

cleaning in place

2-13.7

working range

3-12

Capacità

≥30 mg binding capacity (humanlgG/ml at 2.4 min residence time)

Compatibilità

suitable for bioprocess medium

Temperatura di conservazione

2-8°C

Descrizione generale

Determined at 10% breakthrough by frontal analysis at a mobile phase velocity of 500 cm/h in a column with a bed height of 20 cm.
MabSelect SuRe is a protein A affinity medium for capturing MAbs at process scale. MabSelect SuRe has an alkali-tolerant rProtein A ligand that allows the use of rigorous and cost-effective CIP and sanitization protocols based on 0.1 to 0.5 M NaOH. Further, the ligand is protease stable leading to lower ligand leakage.

MabSelect SuRe is a member of the MabSelect family of affinity chromatography media for the capture of monoclonal antibodies (MAbs) at process scale. MabSelect SuRe shares features and benefits of MabSelect such as a rigid, high-flow agarose matrix that ensures excellent pressure/flow properties, low non-specific binding that leads to low impurity levels in the eluate pool, and an oriented ligand coupling for optimal binding capacity. In addition, MabSelect SuRe features an alkali-tolerant rProtein A ligand. This ligand provides greater stability than conventional protein A-based media in the alkaline conditions used in cleaning-in-place (CIP) and sanitization protocols. The enhanced alkali stability of MabSelect SuRe improves process economy and product quality; cleaning can be performed with cost-effective reagents such as sodium hydroxide eliminating the need for expensive and hazardous cleaning agents such as Gua-HCl.

The novel ligand construct of MabSelect SuRe has been proven to have an increased stability towards proteases. Therefore, the level of leakage of the MabSelect SuRe ligand during elution is low.

MabSelect SuRe has been demonstrated to give generic elution conditions for different monoclonal antibodies, which is an advantage when designing generic purification platform processes. This feature is also correlated to the construction of the MabSelect SuRe ligand.

MabSelect SuRe is available in a range of different bulk pack sizes and convenient pre-packed formats for easy scale-up and process development. As member of the BioProcess media range, MabSelect SuRe meets industrial demands with security of supply and comprehensive technical and regulatory support.
pH below 3 is sometimes required to elute strongly bound IgG species. However, protein ligands may hydrolyze at very low pH.
pH below 3 is sometimes required to elute strongly bound IgG species. However, protein ligands may hydrolyze at very low pH.

Caratteristiche e vantaggi

  • Novel, alkali-tolerant rProtein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH.
  • Reduces the risk of product contamination and carryover
  • Improves product quality and reduces overall costs
  • Novel ligand design gives enhanced protease resistance resulting in lower ligand leakage
  • Generic elution profile for different monoclonal antibodies enables platform approach to purification
  • Used in the commercial manufacture of monoclonal antibodies
  • High-flow agarose matrix allows the processing of large feed volumes

Stoccaggio e stabilità

Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.

Risultati analitici

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Note legali

Free MabSelect SuRe Ligand
"MabSelect SuRe Ligand Restricted License" and "Cys-rProtein A Ligand Restricted License" are protected by the following patents and equivalent patents and patent applications in other countries: US 6,399,750 and EP 1123389. A free, non-transferable limited license to use this product for internal analytical purposes only accompanies the purchase of the product from a Cytiva company and its licensed distributors. Any other use will require a separate license from a Cytiva company.
MabSelect is a trademark of Cytiva
SuRe is a trademark of Cytiva

Pittogrammi

Flame

Avvertenze

Warning

Indicazioni di pericolo

Codice della classe di stoccaggio

3 - Flammable liquids


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Articoli

Description of viral clearance using Capto adhere from GE Healthcare.

Capto adhere from GE Healthcare is a multimodal strong anion exchanger for BioProcess applications.

This page describes the difference between bind/elute and flowthrough modes in multimodal chromatography using GE Healthcare products.

This page describes the optimization of loading conditions on Capto adhere from GE Healthcare using full factorial design of experiments (DoE).

Vedi tutto

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.